According to a new market report published by Lucintel, the future of the pharmaceutical robot market looks promising with opportunities in the picking, packaging, inspection of pharmaceutical drug, and laboratory applications. The pharmaceutical robot market is expected to grow with a CAGR of 13% from 2019 to 2024. The major growth drivers for this market are increasing automation and with reduced human intervention in pharmaceutical manufacturing and growth in healthcare industry.
In this market, traditional and collaborative robots are the major robot types. Traditional robot is the largest segment. However, collaborative segment is expected to witness the highest growth over the forecast period due to lightweight, low cost and easier maintenance as compared to traditional ones.
Asia Pacific will remain the largest region over the forecast period due to presence of a large number of local pharmaceutical companies in countries like Japan. China is the largest market for industrial robots.
Kawasaki Heavy Industries, Fanuc, Kuka, ABB, Yaskawa Electric, Mitsubishi Electric, Denso Wave Incorporated, Seiko Epson, Marchesini Group, Universal Robot A/S., and Shibuya are among the major manufacturers of pharmaceutical robots.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the pharmaceutical robot market by robot type, application, end use and region. Lucintel has prepared a comprehensive research report titled "Pharmaceutical Robot Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the pharmaceutical robot market by robot type, application, end use and region as follows:
By Robot Type [$M shipment analysis for 2013 – 2024]:
• Traditional Robot
o Articulated Robot
o SCARA (Selective Compliance Articulated Robot Arm) Robot
o Delta/Parallel Robot
o Cartesian Robot
o Others
• Collaborative Robot
By Application [$M shipment analysis for 2013 – 2024]:
• Picking and Packaging
• Inspection of Pharmaceutical Drugs
• Laboratory Applications
By End Use [$M shipment analysis for 2013 – 2024]:
• Pharmaceutical
• Research Laboratories
By Region [$M shipment analysis for 2013 – 2024]:
• North America
• United States
• Canada
• Mexico
• Europe
• UK
• Germany
• Italy
• Asia Pacific
• China
• Japan
• India
• Rest of the World
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this ……. [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the pharmaceutical robot market by robot type (traditional robots, articulated robots, SCARA (selective compliance articulated robot arm) robots, delta/parallel robots, cartesian robots, other robots (spherical robots and dual-arm robots), and collaborative robots), application (picking and packaging, inspection of pharmaceutical drugs, and laboratory applications), end use (pharmaceutical and research laboratories), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the pharmaceutical robot market?
Q.5. What are the business risks and threats to the pharmaceutical robot market?
Q.6. What are emerging trends in this pharmaceutical robot market and the reasons behind them?
Q.7. What are some changing demands of customers in the pharmaceutical robot market?
Q.8. What are the new developments in the pharmaceutical robot market? Which companies are leading these developments?
Q.9. Who are the major players in this pharmaceutical robot market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this pharmaceutical robot area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in pharmaceutical robot market?